Mercer Global Advisors
MREO

Mercer Global Advisors’s Mereo BioPharma MREO Stock Holding History

Mercer Global Advisors’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71 Buy
+225
New +$67 ﹤0.01% 5990

Other funds holding MREO

TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JJBC
James J. Burns & Company Melville, New York $924M AUM 22.18% 1-Year Est. Return
JF
JMN Financial New Albany, Ohio $129M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SWP
Significant Wealth Partners Cary, Illinois $92.4M AUM 9.22% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return

Mercer Global Advisors's MREO Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Mereo BioPharma (MREO) in Q2 2026: 225 shares worth $71. The stake represents ﹤0.01% of the portfolio and ranks #5990 among its holdings.

24 funds tracked by Wall St. Rank hold MREO as of Q2 2026.

  • Mercer Global Advisors held 225 shares of Mereo BioPharma worth $71 as of Q2 2026.
  • Mereo BioPharma was a new Mercer Global Advisors position in Q2 2026.
  • Mereo BioPharma made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5990 holding.
  • 24 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.